Safety of jakinibs: lessons from ORAL Surveillance.

Bukhari, Marwan; Bergman, Martin; Giles, Jon T; Lozada, Carlos; Cush, John; Yamaoka, Kunihiro; McKay, Catriona; Kavanaugh, Arthur

Bukhari, Marwan; Bergman, Martin; Giles, Jon T; Lozada, Carlos; Cush, John; Yamaoka, Kunihiro; McKay, Catriona; Kavanaugh, Arthur.

Afiliação

Bukhari M; Department of Rheumatology, University Hospitals of Morecambe Bay NHS Foundation Trust, Royal Lancaster Infirmary, Lancaster, UK.
Bergman M; Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, PA.
Giles JT; Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.
Lozada C; Division of Rheumatology and Immunology, University of Miami Miller School of Medicine, Miami, FL.
Cush J; Department of Rheumatology, RheumNow, Dallas, TX, USA.
Yamaoka K; Department of Rheumatology, St George's University School of Medicine, Grenada, West Indies.
McKay C; Department of Rheumatology, Kitasato University School of Medicine, Sagamihara, Japan.
Kavanaugh A; Department of Rheumatology, McKay Morley Medical, Brighton, UK.

Rheumatology (Oxford) ; 61(11): 4223-4225, 2022 11 02.

Article em En | MEDLINE | ID: mdl-35323916

Assuntos

Inibidores de Janus Quinases; Humanos; Janus Quinases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Janus Quinases Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google